Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FSZ18
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,042
Award facts
- Contract value 100% obligated
- $82,041.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda (pembrolizumab) 100 mg/4 mL vials. This firm fixed-price delivery order, valued at $82,041.50, is scheduled for completion by September 2, 2025, and was awarded on August 11, 2025. The delivery order does not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement market based on its woman-owned small business status and competitive capabilities.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.999 billion and valid through November 2026. The IDC authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facility needs worldwide. As a crucial supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription drugs and specialty medications, including oncology treatments such as Keytruda, to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FSZ18?
SPE2DB25FSZ18 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FSZ18 worth?
The government has obligated $82,042 on SPE2DB25FSZ18.
Is contract SPE2DB25FSZ18 an order under another contract?
Yes. SPE2DB25FSZ18 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ18 competed?
The extent of competition for SPE2DB25FSZ18 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award